151 related articles for article (PubMed ID: 31180533)
1. Epigenetic modulators hydralazine and sodium valproate act synergistically in VEGI-mediated anti-angiogenesis and VEGF interference in human osteosarcoma and vascular endothelial cells.
Kumanishi S; Yamanegi K; Nishiura H; Fujihara Y; Kobayashi K; Nakasho K; Futani H; Yoshiya S
Int J Oncol; 2019 Jul; 55(1):167-178. PubMed ID: 31180533
[TBL] [Abstract][Full Text] [Related]
2. Sodium valproate, a histone deacetylase inhibitor, modulates the vascular endothelial growth inhibitor-mediated cell death in human osteosarcoma and vascular endothelial cells.
Yamanegi K; Kawabe M; Futani H; Nishiura H; Yamada N; Kato-Kogoe N; Kishimoto H; Yoshiya S; Nakasho K
Int J Oncol; 2015 May; 46(5):1994-2002. PubMed ID: 25778932
[TBL] [Abstract][Full Text] [Related]
3. Sodium Valproate Enhances Semaphorin 3A-mediated Anti-angiogenesis and Tumor Growth Inhibition in Human Osteosarcoma Cells.
Sawai T; Yamanegi K; Nishiura H; Futani H; Tachibana T
Anticancer Res; 2023 Jun; 43(6):2539-2550. PubMed ID: 37247909
[TBL] [Abstract][Full Text] [Related]
4. TNFSF15 suppresses VEGF production in endothelial cells by stimulating miR-29b expression via activation of JNK-GATA3 signals.
Zhang K; Cai HX; Gao S; Yang GL; Deng HT; Xu GC; Han J; Zhang QZ; Li LY
Oncotarget; 2016 Oct; 7(43):69436-69449. PubMed ID: 27589684
[TBL] [Abstract][Full Text] [Related]
5. Suppression of renal cell carcinoma growth in vivo by forced expression of vascular endothelial growth inhibitor.
Zhang N; Wu P; Shayiremu D; Wu L; Shan H; Ye L; Zhao X; Cai J; Jiang WG; Gong K; Yang Y
Int J Oncol; 2013 May; 42(5):1664-73. PubMed ID: 23545578
[TBL] [Abstract][Full Text] [Related]
6. Distinct Expression Patterns of Two Tumor Necrosis Factor Superfamily Member 15 Gene Isoforms in Human Colon Cancer.
Ślebioda TJ; Stanisławowski M; Cyman M; Wierzbicki PM; Żurawa-Janicka D; Kobiela J; Makarewicz W; Guzek M; Kmieć Z
Dig Dis Sci; 2019 Jul; 64(7):1857-1867. PubMed ID: 30788683
[TBL] [Abstract][Full Text] [Related]
7. Valproic acid cooperates with hydralazine to augment the susceptibility of human osteosarcoma cells to Fas- and NK cell-mediated cell death.
Yamanegi K; Yamane J; Kobayashi K; Kato-Kogoe N; Ohyama H; Nakasho K; Yamada N; Hata M; Fukunaga S; Futani H; Okamura H; Terada N
Int J Oncol; 2012 Jul; 41(1):83-91. PubMed ID: 22576685
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth inhibitor (VEGI) is an independent indicator for invasion in human pituitary adenomas.
Jia W; Sander AJ; Jia G; Ni M; Liu X; Lu R; Jiang WG
Anticancer Res; 2013 Sep; 33(9):3815-22. PubMed ID: 24023314
[TBL] [Abstract][Full Text] [Related]
9. Death receptor 3 mediates TNFSF15- and TNFα-induced endothelial cell apoptosis.
Xu LX; Grimaldo S; Qi JW; Yang GL; Qin TT; Xiao HY; Xiang R; Xiao Z; Li LY; Zhang ZS
Int J Biochem Cell Biol; 2014 Oct; 55():109-18. PubMed ID: 25161149
[TBL] [Abstract][Full Text] [Related]
10. Upregulation and nuclear localization of TNF-like cytokine 1A (TL1A) and its receptors DR3 and DcR3 in psoriatic skin lesions.
Bamias G; Evangelou K; Vergou T; Tsimaratou K; Kaltsa G; Antoniou C; Kotsinas A; Kim S; Gorgoulis V; Stratigos AJ; Sfikakis PP
Exp Dermatol; 2011 Sep; 20(9):725-31. PubMed ID: 21672030
[TBL] [Abstract][Full Text] [Related]
11. CCL3 promotes angiogenesis by dysregulation of miR-374b/ VEGF-A axis in human osteosarcoma cells.
Liao YY; Tsai HC; Chou PY; Wang SW; Chen HT; Lin YM; Chiang IP; Chang TM; Hsu SK; Chou MC; Tang CH; Fong YC
Oncotarget; 2016 Jan; 7(4):4310-25. PubMed ID: 26713602
[TBL] [Abstract][Full Text] [Related]
12. CCL5/CCR5 axis induces vascular endothelial growth factor-mediated tumor angiogenesis in human osteosarcoma microenvironment.
Wang SW; Liu SC; Sun HL; Huang TY; Chan CH; Yang CY; Yeh HI; Huang YL; Chou WY; Lin YM; Tang CH
Carcinogenesis; 2015 Jan; 36(1):104-14. PubMed ID: 25330803
[TBL] [Abstract][Full Text] [Related]
13. Melatonin regulates tumor angiogenesis via miR-424-5p/VEGFA signaling pathway in osteosarcoma.
Vimalraj S; Saravanan S; Raghunandhakumar S; Anuradha D
Life Sci; 2020 Sep; 256():118011. PubMed ID: 32592723
[TBL] [Abstract][Full Text] [Related]
14. VEGI-armed oncolytic adenovirus inhibits tumor neovascularization and directly induces mitochondria-mediated cancer cell apoptosis.
Xiao T; Fan JK; Huang HL; Gu JF; Li LY; Liu XY
Cell Res; 2010 Mar; 20(3):367-78. PubMed ID: 19918267
[TBL] [Abstract][Full Text] [Related]
15. Advancement in the research on vascular endothelial growth inhibitor (VEGI).
Duan L; Yang G; Zhang R; Feng L; Xu C
Target Oncol; 2012 Mar; 7(1):87-90. PubMed ID: 22388993
[TBL] [Abstract][Full Text] [Related]
16. Inhibition of endothelial progenitor cell differentiation by VEGI.
Tian F; Liang PH; Li LY
Blood; 2009 May; 113(21):5352-60. PubMed ID: 19329781
[TBL] [Abstract][Full Text] [Related]
17. The endothelial cell-produced antiangiogenic cytokine vascular endothelial growth inhibitor induces dendritic cell maturation.
Tian F; Grimaldo S; Fujita M; Cutts J; Vujanovic NL; Li LY
J Immunol; 2007 Sep; 179(6):3742-51. PubMed ID: 17785811
[TBL] [Abstract][Full Text] [Related]
18. A novel secreted splice variant of vascular endothelial cell growth inhibitor.
Chew LJ; Pan H; Yu J; Tian S; Huang WQ; Zhang JY; Pang S; Li LY
FASEB J; 2002 May; 16(7):742-4. PubMed ID: 11923219
[TBL] [Abstract][Full Text] [Related]
19. Tumour necrosis factor superfamily member 15 (Tnfsf15) facilitates lymphangiogenesis via up-regulation of Vegfr3 gene expression in lymphatic endothelial cells.
Qin TT; Xu GC; Qi JW; Yang GL; Zhang K; Liu HL; Xu LX; Xiang R; Xiao G; Cao H; Wei Y; Zhang QZ; Li LY
J Pathol; 2015 Nov; 237(3):307-18. PubMed ID: 26096340
[TBL] [Abstract][Full Text] [Related]
20. Soluble decoy receptor 3 induces angiogenesis by neutralization of TL1A, a cytokine belonging to tumor necrosis factor superfamily and exhibiting angiostatic action.
Yang CR; Hsieh SL; Teng CM; Ho FM; Su WL; Lin WW
Cancer Res; 2004 Feb; 64(3):1122-9. PubMed ID: 14871847
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]